Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes

In SURPASS-PEDS, Mounjaro met the primary and all key secondary endpoints at 30 weeks and showed sustained improvement in glycemic control and continued BMI reduction through the study’s 52-week extension  The safety and tolerability profile of Mounjaro was generally consistent with previous adult studies INDIANAPOLIS, Sept. 17, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: […]

DOW INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Dow Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, Sept. 17, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow class action lawsuit. […]

EADV-Kongress 2025: GLP-1RA-Medikamente verringern das Sterbe- und Herz-Kreislauf-Risiko bei Psoriasis-Patienten drastisch

PARIS, 18. September 2025 /PRNewswire/ — Psoriasis-Patienten, die mit Glucagon-like Peptide-1-Rezeptor-Agonisten (GLP-1RAs) behandelt werden, haben ein um 78 % geringeres Sterberisiko und ein um 44 % geringeres Risiko für schwerwiegende kardiovaskuläre Ereignisse im Vergleich zu denjenigen, die andere Diabetes- oder Gewichtsreduktionsmedikamente einnehmen, wie neue Forschungsergebnisse zeigen. Die Studie – die größte ihrer Art, die heute […]

Prologis to Announce Third Quarter 2025 Results October 15th

SAN FRANCISCO, Sept. 17, 2025 /PRNewswire/ — Prologis, Inc. (NYSE: PLD) will host a webcast and conference call with senior management to discuss its third quarter results, current market conditions and future outlook on Wednesday, October 15, 2025, at 9:00 a.m. PT/12:00 p.m. ET. To access a live broadcast of the call, please dial +1 […]

Nucor Announces Guidance for the Third Quarter of 2025 Earnings

CHARLOTTE, N.C., Sept. 17, 2025 /PRNewswire/ — Nucor Corporation (NYSE: NUE) today announced guidance for its third quarter ending October 4, 2025. Nucor expects third quarter earnings to be in the range of $2.05 to $2.15 per diluted share. Nucor reported net earnings of $2.60 per diluted share in the second quarter of 2025 and […]

TriNet Announces Quarterly Dividend

DUBLIN, Calif., Sept. 17, 2025 /PRNewswire/ — TriNet (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses (SMBs),  today announced its Board of Directors approved a dividend of $0.275 per share of the Company’s common stock with a record date and ex-dividend date of October 1, 2025 and a payout […]

Expedition Infrastructure Partners Supports OTG Acquisition Corp. I, a Newly Closed $230 mm SPAC Targeting the Digital Infrastructure Ecosystem

NEW YORK, Sept. 17, 2025 /PRNewswire/ — Expedition Infrastructure Partners (“XIP”) is pleased to announce its role as strategic institutional advisor to OTG Acquisition Corp. I (NASDAQ: OTGAU, “OTG”), which has raised $230 million in its recently closed initial public offering. OTG is targeting businesses across the Digital Infrastructure Services sector, a market experiencing unprecedented growth […]